SANDLER LAURA LEE enters ORUKA THERAPEUTICS, INC. with 213.08K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/1/2025ACC: 0001062993-25-012405
Officer· Chief Operating Officer
Since Mar 2026
213.08K
Baseline shares
100% direct
213.08K
Direct ownership
1 position
237.50K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned213.08K
Total
213.08K direct213.08K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 213.08K | Direct |
| Total | 213.08K | 213.08K direct |
Derivative Holdings2
Warrant (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
7.8
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
137.50K
Shares owned
N/A
Exercise price
12.5
Expiration
—
Exercise window
—
Total
Underlying
237.50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock | 7.8 | — | — | 100K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 12.5 | — | — | 137.50K | N/A |
| Total | 237.50K | 0.00 | ||||